Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study.
Jpn J Clin Oncol
; 48(11): 1012-1021, 2018 Nov 01.
Article
in En
| MEDLINE
| ID: mdl-30371895
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Prednisone
/
Asian People
/
Abiraterone Acetate
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Jpn J Clin Oncol
Year:
2018
Type:
Article